COVID-19 disease in children and adolescents following allogeneic hematopoietic stem cell transplantation: A report from the Turkish pediatric bone marrow transplantation study group.
Ceyhun BozkurtVolkan HazarBaris MalboraAlphan KüpesizUtku AygünesTunç FışgınMusa KarakükçüBulent Baris KuskonmazSuar Çakı KılıçDerya BayırlıÖzlem Arman BilirKoray YalÇinSalih ÖzmenVedat UygunMurat ElliHakan SarbayFunda Tayfun KüpesizHatice İlgen ŞaşmazBasak Adakli AksoyEbru YılmazFatma Visal OkurFunda TekkeşinFatma Demir YenigürbüzGülcihan ÖzekAbdullah Avni Atayİkbal Ok BozkayaSuna ÇelenSeda ÖztürkmenAdalet Meral GüneşOrhan GürselElif GülerAlper ÖzcanDuygu Uçkan ÇetinkayaSelime AydoğduNamık Yaşar ÖzbekGülsün KarasuGulay SezginÖmer DoğruDavut AlbayrakGülyüz ÖztürkSerap AksoylarHayriye DaloğluIşık Odaman AlMelike Sezgin EvimSinan AkbayramYurday ÖncülEmine ZenginCanan AlbayrakÇetin TimurYeter Düzenli KarHasan Fatih ÇakmaklıÖzlem TüfekçiErsin TöretBülent AntmenPublished in: Pediatric transplantation (2024)
While COVID-19 is mostly asymptomatic or mild in pediatric transplant recipients, it can cause ICU admission in those with LRTD or lymphopenia at diagnosis and may be more fatal in those who are transplanted from a mismatched donor and those who develop MIS-C or LRTD.
Keyphrases
- allogeneic hematopoietic stem cell transplantation
- coronavirus disease
- sars cov
- bone marrow
- acute lymphoblastic leukemia
- acute myeloid leukemia
- intensive care unit
- emergency department
- mesenchymal stem cells
- respiratory syndrome coronavirus
- mechanical ventilation
- stem cells
- cell therapy
- acute respiratory distress syndrome